TDTran Do

Tran Do

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tran Do has a total of 83 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Leveraging AI Large Language Models for Writing Clinical Trial Proposals in Dermatology: Instrument Validation Study

    by Megan Hauptman, Daniel Copley, Kelly Young, Tran Do, Joseph S Durgin, Albert Yang, Jungsoo Chang, Allison Billi, Mio Nakamura, Trilokraj Tejasvi

    Background: Large language models (LLMs) are becoming increasingly popular in clinical trial design but have been underused in research proposal development. Objective: This study compared the performance of commonly used open access LLMs versus human proposal composition and review. Methods: A total of 10 LLMs were prompted to write a research proposal. Six physicians and each of the LLMs assessed 11 blinded proposals for capabilities and limitations in accuracy and comprehensiveness. Results: ChatGPT-o1 and Llama 3.1 were rated the most and least accurate, respectively, by human scorers. LLM scorers rated ChatGPT-o1 and DeepSeek R1 as the most accurate. ChatGPT-o1 and Llama 3.1 were rated as the most and least comprehensive, respectively, by human and LLM scorers. LLMs performed poorly on scoring proposals and, on average, rated proposals 1.9 points higher than humans for both accuracy and comprehensiveness. Conclusions: Paid versions of ChatGPT remain the highest-quality and most versatile option of the available LLMs. These tools cannot replace expert input but serve as powerful assistants, streamlining the development process and enhancing productivity.

  • Open Access

    Leveraging Artificial Intelligence Large Language Models for Writing Clinical Trial Proposals in Dermatology (Preprint)

    by Megan Hauptman, Daniel Copley, Kelly Young, Tran Do, Joseph Durgin, Albert Yang, Jungsoo Chang, Allison Billi, Mio Nakamura, Trilokraj Tejasvi

    BACKGROUND Large language models (LLMs) are becoming increasingly popular in clinical trial design but have been underutilized in research proposal development. OBJECTIVE This study compares the performance of commonly used open access LLMs versus human proposal composition and review. METHODS Ten LLMs were prompted to write a research proposal. Six physicians and each of the LLMs assessed 11 blinded proposals for capabilities and limitations in accuracy and comprehensiveness. RESULTS Chat GPT o1 was rated the most accurate and LLaMA 3.1 the least accurate by human scorers. LLM scorers rated Chat GPT o1 and Deepseek R1 the most accurate. Chat GPT o1 was the most comprehensive and LLaMA 3.1 the least comprehensive by human and LLM scorers. LLMs performed poorly on scoring proposals, and on average rated proposals 1.9 points higher than humans for both accuracy and comprehensiveness. CONCLUSIONS Paid versions of ChatGPT remain the highest quality and most versatile option of available LLMs. These tools cannot replace expert input but serve as powerful assistants, streamlining the development process and enhancing productivity. CLINICALTRIAL n/a

  • Open Access

    Oral Baricitinib in the Treatment of Cutaneous Lichen Planus

    by Angelina Hwang, Jacob Kechter, Tran Do, Alysia Hughes, Nan Zhang, Xing Li, Rachael Wasikowski, Caitlin Brumfiel, Meera Patel, Blake Boudreaux, et al.

    Background: Cutaneous lichen planus (LP) is a recalcitrant, difficult-to-treat, inflammatory skin disease characterized by pruritic, flat-topped, violaceous papules on the skin. Baricitinib is an oral Janus kinase (JAK) 1/2 inhibitor that interrupts the signaling pathway of interferon (IFN)-γ, a cytokine implicated in the pathogenesis of LP. Methods: In this phase II trial, twelve patients with cutaneous LP received baricitinib 2 mg daily for 16 weeks, accompanied by in-depth spatial, single-cell, and bulk transcriptomic profiling of pre-and post-treatment samples. Results: An early and sustained clinical response was seen with 83.3% of patients responsive at week 16. Our molecular data identified a unique, oligoclonal IFN-γ, CD8+, CXCL13+ cytotoxic T-cell population in LP skin and demonstrate a rapid decrease in interferon signature within 2 weeks of treatment, most prominent in the basal layer of the epidermis. Conclusion: This study demonstrates the efficacy and molecular mechanisms of JAK inhibition in LP. Trial Registration Number : NCT05188521


  • Open Access

    Genetic and Functional Analyses of Cutibacterium Acnes Isolates Reveal the Association of a Linear Plasmid with Skin Inflammation

    by Alan M. O’neill, Kellen J. Cavagnero, Jason S. Seidman, Livia Zaramela, Yang Chen, Fengwu Li, Teruaki Nakatsuji, Joyce Y. Cheng, Yun L. Tong, Tran H. Do, et al.


  • Top Cited Papers

    TREM2 macrophages induced by human lipids drive inflammation in acne lesions

    by Tran H. Do, Feiyang Ma, Priscila R. Andrade, Rosane Teles, Bruno J. de Andrade Silva, Chanyue Hu, Alejandro Espinoza, Jer-En Hsu, Chun-Seok Cho, Myungjin Kim, et al.

    Acne affects 1 in 10 people globally, often resulting in disfigurement. The disease involves excess production of lipids, particularly squalene, increased growth of Cutibacterium acnes , and a host inflammatory response with foamy macrophages. By combining single-cell and spatial RNA sequencing as well as ultrahigh-resolution Seq-Scope analyses of early acne lesions on back skin, we identified TREM2 macrophages expressing lipid metabolism and proinflammatory gene programs in proximity to hair follicle epithelium expressing squalene epoxidase. We established that the addition of squalene induced differentiation of TREM2 macrophages in vitro, which were unable to kill C. acnes . The addition of squalene to macrophages inhibited induction of oxidative enzymes and scavenged oxygen free radicals, providing an explanation for the efficacy of topical benzoyl peroxide in the clinical treatment of acne. The present work has elucidated the mechanisms by which TREM2 macrophages and unsaturated lipids, similar to their involvement in atherosclerosis, may contribute to the pathogenesis of acne.


  • Histidine‐Mediated Ion Specific Effects Enable Salt Tolerance of a Pore‐Forming Marine Antimicrobial Peptide

    by Wujing Xian, Matthew R. Hennefarth, Michelle W. Lee, Tran Do, Ernest Y. Lee, Anastassia N. Alexandrova, Gerard C. L. Wong

    Antimicrobial peptides (AMPs) preferentially permeate prokaryotic membranes via electrostatic binding and membrane remodeling. Such action is drastically suppressed by high salt due to increased electrostatic screening, thus it is puzzling how marine AMPs can possibly work. We examine as a model system, piscidin‐1, a histidine‐rich marine AMP, and show that ion‐histidine interactions play unanticipated roles in membrane remodeling at high salt: Histidines can simultaneously hydrogen‐bond to a phosphate and coordinate with an alkali metal ion to neutralize phosphate charge, thereby facilitating multidentate bonds to lipid headgroups in order to generate saddle‐splay curvature, a prerequisite to pore formation. A comparison among Na+, K+, and Cs+ indicates that histidine‐mediated salt tolerance is ion specific. We conclude that histidine plays a unique role in enabling protein/peptide‐membrane interactions that occur in marine or other high‐salt environment.


  • Histidine‐Mediated Ion Specific Effects Enable Salt Tolerance of a Pore‐Forming Marine Antimicrobial Peptide

    by Wujing Xian, Matthew R. Hennefarth, Michelle W. Lee, Tran Do, Ernest Y. Lee, Anastassia N. Alexandrova, Gerard C. L. Wong

    Antimicrobial peptides (AMPs) preferentially permeate prokaryotic membranes via electrostatic binding and membrane remodeling. Such action is drastically suppressed by high salt due to increased electrostatic screening, thus it is puzzling how marine AMPs can possibly work. We examine as a model system, piscidin‐1, a histidine‐rich marine AMP, and show that ion‐histidine interactions play unanticipated roles in membrane remodeling at high salt: Histidines can simultaneously hydrogen‐bond to a phosphate and coordinate with an alkali metal ion to neutralize phosphate charge, thereby facilitating multidentate bonds to lipid headgroups in order to generate saddle‐splay curvature, a prerequisite to pore formation. A comparison among Na+, K+, and Cs+ indicates that histidine‐mediated salt tolerance is ion specific. We conclude that histidine plays a unique role in enabling protein/peptide‐membrane interactions that occur in marine or other high‐salt environment.


  • Antimicrobial production by perifollicular dermal preadipocytes is essential to the pathophysiology of acne

    by Alan M. O’nEill, Marc C. Liggins, Jason S. Seidman, Tran H. Do, Fengwu Li, Kellen J. Cavagnero, Tatsuya Dokoshi, Joyce Y. Cheng, Faiza Shafiq, Tissa R. Hata, et al.

    Innate immune defense against deep tissue infection by Staphylococcus aureus is orchestrated by fibroblasts that become antimicrobial when triggered to differentiate into adipocytes. However, the role of this process in noninfectious human diseases is unknown. To investigate the potential role of adipogenesis by dermal fibroblasts in acne, a disorder triggered by Cutibacterium acnes , single-cell RNA sequencing was performed on human acne lesions and mouse skin challenged by C. acnes . A transcriptome consistent with adipogenesis was observed within specific fibroblast subsets from human acne and mouse skin lesions infected with C. acnes . Perifollicular dermal preadipocytes in human acne and mouse skin lesions showed colocalization of PREF1, an early marker of adipogenesis, and cathelicidin ( Camp ), an antimicrobial peptide. This capacity of C. acnes to specifically trigger production of cathelicidin in preadipocytes was dependent on TLR2. Treatment of wild-type mice with retinoic acid (RA) suppressed the capacity of C. acnes to form acne-like lesions, inhibited adipogenesis, and enhanced cathelicidin expression in preadipocytes, but lesions were unresponsive in Camp −/− mice, despite the anti-adipogenic action of RA. Analysis of inflamed skin of acne patients after retinoid treatment also showed enhanced induction of cathelicidin, a previously unknown beneficial effect of retinoids in difficult-to-treat acne. Overall, these data provide evidence that adipogenic fibroblasts are a critical component of the pathogenesis of acne and represent a potential target for therapy.


  • Phototherapy trends in dermatology 2015–2018

    by Aislyn Oulee, Sogol S. Javadi, Amylee Martin, Tran Do, Jashin J. Wu

    Background: Trends in phototherapy utilization including its main clinical indications were last characterized by Luersen et al. for the time period of 1997-2010. In this study, we update data on the use of phototherapy in the United States from 2015-2018. Methods: We queried the National Ambulatory Medical Care Survey (NAMCS) data on number of phototherapy visits as well as demographics and associated dermatoses. Results: There were an approximately 1.31 million outpatient phototherapy visits during the study period with a decreasing trend over time. Leading indications for phototherapy were dermatitis not otherwise specified (NOS), (25.7%) followed by atopic dermatitis (AD) (11.7%), and pruritus (9.7%). Conclusion: There is a downtrend in the use of phototherapy from 2015-2018. Psoriasis is no longer the main indication for phototherapy, which may be due to the advent of highly effective novel biologics.